Live Breaking News & Updates on ஹீலி மையம்

Stay updated with breaking news from ஹீலி மையம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lou Gehrig Day June 2nd 2021 details


4:58 PM UTC
share-square-1975362
A special collection of activities has been coordinated by Major League Baseball, its Clubs and the Lou Gehrig Day Committee to celebrate the inaugural “Lou Gehrig Day” on Wednesday, June 2nd. These efforts include special moments at Major League ballparks and a series of fundraising efforts aimed at supporting charitable organizations, notably the Expanded Access Protocol (EAP) program at the Sean M. Healey and AMG Center for ALS at Massachusetts General Hospital (Healey Center for ALS).
“4th
INNING” VIDEO FEATURE STARRING STEVE GLEASON
ALS Advocate Steve Gleason will be featured in a special ballpark moment highlighted during the 4th inning (or pregame in some ballparks) of all Lou Gehrig Day games. During this moment, a video created especially for Lou Gehrig Day will be shown to offer a glimpse into Gleason’s own voice as he recites a part of Gehrig’s famous “Luckiest Man” retirement speech. This opportunity ....

New York , United States , Boston College , Steve Gleason , Ripken Jr , Eleanor Gehrig , Lou Gehrig , Seanm Healey , Famer Lou Gehrig , Nancy Frates , Jackie Robinson , Roberto Clemente , Pete Frates , Stephen Piscotty , Therapy Development Institute , Healey Center , Major League , Major League Baseball , Google Research , Association Home Health Initiative , Winter Meetings Charity Auction , Hospital Healey Center , Showcase The Healey Center , Lou Gehrig Day Committee , Access Protocol Program , Summer Slugger Program ,

New research supports pridopidine's neuroprotective properties in Huntington's Disease models


 E-Mail
Newly published papers further elucidate the mechanisms underlying pridopidine s neuroprotective properties through activation of the Sigma-1 Receptor (S1R).
Pridopidine enhances mitochondrial function and reduces mHTT-induced ER stress, which are impaired in HD, mediated by the S1R.
Three new peer-reviewed publications highlight pridopidine s therapeutic potential and provide data supporting the role of the S1R in neurodegenerative diseases
Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, today announces the publication of three peer-reviewed journal articles, highlighting key aspects of the mechanism of action of its lead asset, pridopidine, and the importance of S1R activation as a mechanism to attenuate biological features of neurodegenerative diseases. ....

Michaelr Hayden , Huntington Study Group , Healey Center , International Journal Of Molecular Sciences , Mediates Pridopidine Rescue , Mitochondrial Function , Huntington Disease Models , Its Role , Neurodegenerative Diseases , International Journal , Molecular Sciences , Amyotrophic Lateral Sclerosis , Global Phase , Total Functional Capacity , Mass General , Health Care , Pharmaceutical Sciences , Medicine Health , Clinical Trials , Health Professionals , ஹண்டிங்டன் படிப்பு குழு , ஹீலி மையம் , சர்வதேச இதழ் ஆஃப் மூலக்கூறு அறிவியல் , மைட்டோகாண்ட்ரியல் செயல்பாடு , அதன் பங்கு , சர்வதேச இதழ் ,